Clinical Trial: DNA Analysis in Predicting Lung Cancer Risk

Clinical Trial: DNA Analysis in Predicting Lung Cancer Risk

Sponsor and Collaborators

National Cancer Institute (NCI)

Contact
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center
888-NCI-1937

Principal Investigator
Elise D. Bowman National Cancer Institute (NCI)

ClinicalTrials.gov Identifier
NCT00559325
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs